JP2024534786A5 - - Google Patents
Info
- Publication number
- JP2024534786A5 JP2024534786A5 JP2024509092A JP2024509092A JP2024534786A5 JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5 JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- nucleic acid
- acid sequence
- antigen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233570P | 2021-08-16 | 2021-08-16 | |
| US63/233,570 | 2021-08-16 | ||
| US202163286952P | 2021-12-07 | 2021-12-07 | |
| US63/286,952 | 2021-12-07 | ||
| PCT/US2022/040317 WO2023022973A2 (en) | 2021-08-16 | 2022-08-15 | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534786A JP2024534786A (ja) | 2024-09-26 |
| JP2024534786A5 true JP2024534786A5 (https=) | 2025-08-13 |
Family
ID=85240944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509092A Pending JP2024534786A (ja) | 2021-08-16 | 2022-08-15 | ポリヌクレオチド両親媒性物質を含有する組成物及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250134992A1 (https=) |
| EP (1) | EP4388102A4 (https=) |
| JP (1) | JP2024534786A (https=) |
| AU (1) | AU2022329730A1 (https=) |
| CA (1) | CA3228856A1 (https=) |
| WO (1) | WO2023022973A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024226775A2 (en) * | 2023-04-26 | 2024-10-31 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide and polypeptide amphiphiles and methods of use thereof |
| KR20260028688A (ko) * | 2023-05-25 | 2026-03-04 | 엘리시오 테라퓨틱스, 인크. | P53 펩티드 양친매체를 함유하는 조성물 및 이의 이용 방법 |
| WO2024243540A1 (en) * | 2023-05-25 | 2024-11-28 | Elicio Therapeutics, Inc. | Compositions containing braf peptide amphiphiles and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004108937A1 (en) * | 2003-06-04 | 2004-12-16 | Bioleaders Corporation | Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| JP5759678B2 (ja) * | 2010-04-14 | 2015-08-05 | 国立大学法人埼玉大学 | 核酸リンカー |
| US9200314B2 (en) * | 2010-07-21 | 2015-12-01 | Takara Bio Inc. | Synthetic siRNA detection method |
| CN112587671A (zh) * | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| EP2892930B1 (en) * | 2012-09-07 | 2019-08-14 | University Of Miami | Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
| KR20220068276A (ko) * | 2013-09-20 | 2022-05-25 | 고쿠리츠 켄큐 카이하츠 호진 이야쿠 키반 켄코 에이요 켄큐쇼 | 면역 부활 활성을 갖는 올리고뉴클레오티드 함유 복합체 및 그 용도 |
| JP2018509387A (ja) * | 2015-01-21 | 2018-04-05 | フェーズアールエックス インコーポレイテッド | 細胞に治療および診断剤を送達するための方法、組成物、ならびにシステム |
| MA52434A (fr) * | 2018-03-02 | 2021-01-06 | Elicio Therapeutics Inc | Amphiphiles cpg et leurs utilisations |
| WO2020191305A2 (en) * | 2019-03-20 | 2020-09-24 | Massachusetts Institute Of Technology | Uses of amphiphiles in immune cell therapy and compositions therefor |
-
2022
- 2022-08-15 AU AU2022329730A patent/AU2022329730A1/en active Pending
- 2022-08-15 EP EP22858990.9A patent/EP4388102A4/en active Pending
- 2022-08-15 WO PCT/US2022/040317 patent/WO2023022973A2/en not_active Ceased
- 2022-08-15 CA CA3228856A patent/CA3228856A1/en active Pending
- 2022-08-15 US US18/684,014 patent/US20250134992A1/en active Pending
- 2022-08-15 JP JP2024509092A patent/JP2024534786A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534786A5 (https=) | ||
| JP7625637B2 (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| JP7763907B2 (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| US7709449B2 (en) | Nucleic acid-based compounds and methods of use thereof | |
| CN111527207A (zh) | GalNAc衍生物 | |
| JP2009515823A (ja) | トール様受容体に基づく免疫反応を調整する免疫調節ヌクレオチド（ｉｒｏ）化合物 | |
| CA2081777A1 (en) | Inhibition of influenza virus replication by oligonucleotides | |
| JP2006515277A5 (https=) | ||
| JPH10510435A (ja) | Ｂ型肝炎ウイルス複製のアンチセンス阻害 | |
| JP2023532290A5 (https=) | ||
| CN115252772A (zh) | 人工合成的含CpG单链脱氧寡核苷酸在疫苗中的应用 | |
| JP2024533371A5 (https=) | ||
| JP2024529875A5 (https=) | ||
| JP2023528016A5 (https=) | ||
| CN121620390A (zh) | 用于调节针对乙型肝炎病毒感染的免疫应答的寡核苷酸 | |
| JP5359883B2 (ja) | 肝炎の治療剤又は予防剤 | |
| CN119452087A (zh) | 用于抑制乙型肝炎病毒的双链核糖核酸 | |
| CN114127292A (zh) | 减轻反义核酸的毒性的方法 | |
| US12163132B2 (en) | Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating COVID 19 | |
| TW202612708A (zh) | 組合治療 | |
| RU2006111336A (ru) | Р185-кодирующая днк и ее терапевтические применения | |
| RU2000121049A (ru) | Антигены neisseria meningitidis | |
| WO2024248367A1 (ko) | 단백질 고효율 발현용 mRNA 구조체 플랫폼 | |
| TW202604544A (zh) | 抑制CTGF基因表達的siRNA及其組合物 | |
| JPWO2024237214A5 (https=) |